1. Doçi, Colleen L, Mikelis, Constantinos M, Lionakis, Michail S, Molinolo, Alfredo A, Gutkind, J Silvio. 2015. Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma. In Cancer research, 75, 2937-48. doi:10.1158/0008-5472.CAN-14-3121. https://pubmed.ncbi.nlm.nih.gov/25952650/
2. Kusy, Sophie, Potiron, Vincent, Zeng, Chan, Drabkin, Harry A, Roche, Joëlle. . Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene. In Biochimica et biophysica acta, 1730, 66-76. doi:. https://pubmed.ncbi.nlm.nih.gov/16005989/
3. Ye, Ke, Ouyang, Xiwu, Wang, Zhiming, Yao, Lei, Zhang, Gewen. 2020. SEMA3F Promotes Liver Hepatocellular Carcinoma Metastasis by Activating Focal Adhesion Pathway. In DNA and cell biology, 39, 474-483. doi:10.1089/dna.2019.4904. https://pubmed.ncbi.nlm.nih.gov/31968181/
4. Zhou, Zhi-hang, Rao, Jun, Yang, Jing, Liu, Xin-dong, Bian, Xiu-wu. 2015. SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis. In The Journal of pathology, 236, 467-78. doi:10.1002/path.4541. https://pubmed.ncbi.nlm.nih.gov/25866254/
5. Aigrot, Marie-Stéphane, Barthelemy, Clara, Moyon, Sarah, Lubetzki, Catherine, Tepavčević, Vanja. 2022. Genetically modified macrophages accelerate myelin repair. In EMBO molecular medicine, 14, e14759. doi:10.15252/emmm.202114759. https://pubmed.ncbi.nlm.nih.gov/35822550/
6. Moragas, Núria, Fernandez-Nogueira, Patricia, Recalde-Percaz, Leire, Carbó, Neus, Fuster, Gemma. 2024. The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma. In Breast cancer research : BCR, 26, 122. doi:10.1186/s13058-024-01871-0. https://pubmed.ncbi.nlm.nih.gov/39138514/
7. Joo, Sun Young, Min, Hyehyun, Kim, Jung Ah, Bok, Jinwoong, Gee, Heon Yung. 2025. Biallelic variants of SEMA3F are associated with nonsyndromic hearing loss. In Molecules and cells, 48, 100190. doi:10.1016/j.mocell.2025.100190. https://pubmed.ncbi.nlm.nih.gov/39909336/